BAPQRTGVNYIZOT-UHFFFAOYSA-N
C30H27F5N6O5 — CID 58164001
Data last refreshed: (MolForge compound catalog, from PubChem)
About BAPQRTGVNYIZOT-UHFFFAOYSA-N
BAPQRTGVNYIZOT-UHFFFAOYSA-N (PubChem CID 58164001) has the molecular formula C30H27F5N6O5 and a molecular weight of 646.57 g/mol. Its IUPAC name is 2-[2-(2,3-difluorophenyl)imidazo[4,5-d]pyridazin-5-yl]-N-[2-(methoxymethoxy)ethyl]-2-[3-[4-propoxy-2-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]acetamide.
Molecular Properties
| Compound Name | BAPQRTGVNYIZOT-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 58164001 |
| Molecular Formula | C30H27F5N6O5 |
| Molecular Weight | 646.57 g/mol |
| Exact Mass | 646.20 |
| IUPAC Name | 2-[2-(2,3-difluorophenyl)imidazo[4,5-d]pyridazin-5-yl]-N-[2-(methoxymethoxy)ethyl]-2-[3-[4-propoxy-2-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]acetamide |
| SMILES | CCCOc1ccc(-c2cc(C(C(=O)NCCOCOC)n3cc4nc(-c5cccc(F)c5F)nc-4cn3)on2)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C30H27F5N6O5/c1-3-10-45-17-7-8-18(20(12-17)30(33,34)35)22-13-25(46-40-22)27(29(42)36-9-11-44-16-43-2)41-15-24-23(14-37-41)38-28(39-24)19-5-4-6-21(31)26(19)32/h4-8,12-15,27H,3,9-11,16H2,1-2H3,(H,36,42) |
| InChIKey | BAPQRTGVNYIZOT-UHFFFAOYSA-N |
| XLogP | 5.51 |
| TPSA | 126.42 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 646.57 |
| LogP ≤ 5 | 5.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58164001 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.